XT
ONC

XTX Topco’s BeOne Medicines Ltd ONC Stock Holding History

XTX Topco’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29M Buy
15,064
+9,911
+192% +$2.92M 0.06% 472
2026
Q1 		$1.53M Sell
5,153
-4,433
-46% -$1.43M 0.03% 1059
2025
Q4 		$2.91M Buy
+9,586
New +$3.14M 0.08% 350
2024
Q4 		– Sell
-7,191
Closed -$1.61M – 3062
2024
Q3 		$1.61M Buy
+7,191
New +$1.29M 0.12% 214
2024
Q1 		– Sell
-1,366
Closed -$246K – 2419
2023
Q4 		$246K Buy
+1,366
New +$247K 0.05% 790
2023
Q3 		– Sell
-1,200
Closed -$214K – 2091
2023
Q2 		$214K Buy
+1,200
New +$276K 0.04% 960
2021
Q3 		– Sell
-1,334
Closed -$458K – 1117
2021
Q2 		$458K Buy
+1,334
New +$442K 0.15% 205

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

XTX Topco's ONC Position: Q2 2026 in Review

XTX Topco increased its BeOne Medicines Ltd (ONC) stake by 192% in Q2 2026, buying an estimated $2.92M and bringing the position to 15,064 shares worth $4.29M. The position accounts for 0.06% of the portfolio, ranked #472.

XTX Topco first reported a position in ONC in Q2 2021 and has held it in 7 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • XTX Topco held 15,064 shares of BeOne Medicines Ltd worth $4.29M as of Q2 2026.
  • XTX Topco bought 9,911 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.92M.
  • BeOne Medicines Ltd made up 0.06% of XTX Topco's portfolio in Q2 2026, its #472 holding.
  • XTX Topco first reported a position in BeOne Medicines Ltd in Q2 2021 and has held it in 7 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.